Acute Porphyria Drugs

R01AX03 - Ipratropium Bromide

Not Porphyrinogenic
NP

Rationale
Hydrophilic substance, insignificant systemic exposure.
Chemical description
Ipratropium bromide, anticholinergic used in treatment (nasal spray 21 - 42 µg/dose) of rhinitis. Plasma levels below detection limit, only 3 - 6 % of the dose recovered in urine.
Ipnet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes
  • R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
  • R01AX Other Nasal Preparations
References
Tradenames

Nasipral Atrovent Atrovent · Nasipral Nasipral · Rinovagos Ipratropium bromide · Rinaspray Atrovent · Iprazap · Lomuspray Atrovent · Rinivent Atrovent · Ipratropium · Lomuspray Atrovent · Atrovent Forte · Ipravent · Univent Ipravent Lomuspray Atrovent · Rinivent Atrovent
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙